We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 2 for:    CB-839 lung

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

This study is currently recruiting participants.
Verified August 2016 by Calithera Biosciences, Inc
Sponsor:
ClinicalTrials.gov Identifier:
NCT02071862
First Posted: February 26, 2014
Last Update Posted: August 22, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Calithera Biosciences, Inc
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2017
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)